January-February 2023 Featured Report

January-February 2023 Featured Report

Featured on January-February 2023 Featured Report

The Next Frontier for Viral-Vector Vaccines: Considerations for Manufacturing and Operations

The Next Frontier for Viral-Vector Vaccines: Considerations for Manufacturing and Operations The Next Frontier for Viral-Vector Vaccines: Considerations for Manufacturing and Operations

byBrian Gazaille, Stefano Colloca

Feb 9, 2023

SARS-CoV-2 Variants: A Case for Expanding mRNA Vaccine Production Globally

SARS-CoV-2 Variants: A Case for Expanding mRNA Vaccine Production Globally SARS-CoV-2 Variants: A Case for Expanding mRNA Vaccine Production Globally

byMahesh Bhalgat

Feb 9, 2023

Leishmaniasis — a Forgotten Epidemic

Leishmaniasis — a Forgotten Epidemic Leishmaniasis — a Forgotten Epidemic

byFlavia D'Alessio, Sophie Houardand 4 more

Feb 9, 2023

Water-Proton Nuclear Magnetic Resonance Spectroscopy: Emerging Applications for Vaccine Quality Assessment

Water-Proton Nuclear Magnetic Resonance Spectroscopy: Emerging Applications for Vaccine Quality Assessment Water-Proton Nuclear Magnetic Resonance Spectroscopy: Emerging Applications for Vaccine Quality Assessment

byBrian Gazaille, Marc B. Taraban

Feb 9, 2023

Production and Purification of Newcastle Disease Virus: A High-Yield Platform Process Based on a Novel Avian Cell Line and Monolith Chromatography

Sponsored Content

Production and Purification of Newcastle Disease Virus: A High-Yield Platform Process Based on a Novel Avian Cell Line and Monolith Chromatography Production and Purification of Newcastle Disease Virus: A High-Yield Platform Process Based on a Novel Avian Cell Line and Monolith Chromatography

byHana Jug, Natalija Hostaand 8 more

Feb 9, 2023

More from January-February 2023 Featured Report